AbbVie (Germany)

Recent papers from AbbVie (Germany)

1. New insights on bridging integrator 1 protein isoforms as a risk increasing gene in Alzheimer’s diseaseFrontiers in Aging Neuroscience · 2026
2. Efficacy and Safety of Risankizumab Among Patients With Ulcerative Colitis in East Asia: A Post Hoc Analysis of Two Randomized Clinical TrialsJournal of Gastroenterology and Hepatology · 2026
3. Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.2026
4. Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 StudiesJournal of Gastroenterology and Hepatology · 2026
5. Upadacitinib for Severe Alopecia Areata in Adults and AdolescentsJAMA Dermatology · 2026
6. Population Pharmacokinetics and Exposure‐Response Analyses to Support Cofetuzumab Pelidotin ( ABBV ‐647) Dose Optimization in Non‐Small Cell Lung Cancer PatientsClinical Pharmacology & Therapeutics · 2026
7. Real-World Evidence for the Impact of Minimal Disease Activity on Quality of Life in Atopic Dermatitis: An Interim Analysis of the Prospective, Multicenter, Non-Interventional UP-TAINED StudyDermatology and Therapy · 2026
8. Characterizing Buffer Exchange in Automated Peptide Mapping Sample Preparation of BiotherapeuticsJournal of Pharmaceutical and Biomedical Analysis · 2026
9. On-Cycle Enforcement in Water: Trimetallic Assemblies Preventing Pd Black Formation While Accelerating Selective Suzuki–Miyaura Coupling without Olefin InterferenceJACS Au · 2026
10. Utilizing chitosan nanoparticles for the delivery of biologics to the brain via intranasal routeMaterials Today Advances · 2026
11. Distinct YY dinucleotide periodicity in adeno-associated virus DNAMolecular Therapy · 2026
12. Dilution displacement enabled measurement of total ligand levels in the presence of an anti-ligand antibody using LBABioanalysis · 2026
13. Sulfoximine and Triazine-Acid Adduct Behavior in Aqueous HPMC: A Fast and Convenient N -Functionalization of SulfoximinesOrganic Process Research & Development · 2026
14. Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND studyInflammatory Bowel Diseases · 2026
15. Large-Scale Collaborative Assessment of Binding Free Energy Calculations for Drug Discovery Using OpenFEJournal of Chemical Information and Modeling · 2026
16. Transmetallation by Halogen-Cyanide Metathesis in Water: Application to Cyanide Ion-Free Palladium Catalyzed CyanationACS Catalysis · 2026
17. Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH studyAnnals of the Rheumatic Diseases · 2026
18. Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a TrialAdvances in Therapy · 2026
19. Long-term safety and efficacy of upadacitinib compared with adalimumab in patients with rheumatoid arthritis: 7-year data from the SELECT-COMPARE studyRMD Open · 2026
20. IQ-MPS Affiliate perspectives on blood-brain barrier microphysiological systems: Progress and challenges aheadALTEX · 2026